Recursive Superintelligence raises $500M to accelerate AI innovation, signaling strong investor confidence in next-gen ...

The reason this matters so much right now is that AI and humans are fundamentally different kinds of intelligence. Despite ...

Marketing claims in AI rarely survive contact with reality. That’s because making real progress in healthcare is hard. To ...

Eid-ul-Fitr 2026 is already here and if you are looking for some stylized AI portraits with family and friends then you have ...

In just a few short months, Marathon has minted a highly quotable line: “Escape will make me God.” It’s also, according to ...

Having trouble with the lengthy Terra Dome of Pragmata? Here's our complete walkthrough for Sector 3, and how to free Eight.

History of DeFi from MakerDAO (2017) to the 78B peak and 2022 collapse. Covers DeFi Summer, yield farming, and post-crash ...

Smart Robotics secures €10M Series A funding to expand its AI-powered robotic picking solutions across Europe, boosting ...

Summit has arrived in Overwatch, bringing with it new hero Sierra and Operation: Grand Mesa, the launch of the Switch 2 ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...